AA
WST icon

ALPS Advisors’s West Pharmaceutical WST Stock Holding History

ALPS Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
2,954
+849
+40% +$260K 0.01% 685
2026
Q1 		$528K Buy
2,105
+290
+16% +$72.2K ﹤0.01% 726
2025
Q4 		$499K Buy
1,815
+15
+0.8% +$4.1K ﹤0.01% 733
2025
Q3 		$472K Buy
+1,800
New +$437K ﹤0.01% 714
2024
Q3 		– Sell
-968
Closed -$319K – 1147
2024
Q2 		$319K Sell
968
-2
-0.2% -$707 ﹤0.01% 817
2024
Q1 		$384K Buy
+970
New +$359K ﹤0.01% 654
2023
Q3 		– Sell
-1,009
Closed -$386K – 1141
2023
Q2 		$386K Buy
1,009
+5
+0.5% +$1.79K ﹤0.01% 668
2023
Q1 		$348K Sell
1,004
-71
-7% -$20.7K ﹤0.01% 685
2022
Q4 		$253K Sell
1,075
-10
-0.9% -$2.37K ﹤0.01% 960
2022
Q3 		$267K Buy
1,085
+190
+21% +$57.9K ﹤0.01% 957
2022
Q2 		$271K Buy
+895
New +$291K ﹤0.01% 895
2022
Q1 		– Sell
-820
Closed -$385K – 996
2021
Q4 		$385K Buy
820
+16
+2% +$6.89K ﹤0.01% 705
2021
Q3 		$341K Sell
804
-433
-35% -$183K ﹤0.01% 789
2021
Q2 		$444K Hold
1,237
– – ﹤0.01% 540
2021
Q1 		$349K Buy
1,237
+307
+33% +$87.9K ﹤0.01% 592
2020
Q4 		$263K Sell
930
-19
-2% -$5.33K ﹤0.01% 794
2020
Q3 		$261K Sell
949
-467
-33% -$124K ﹤0.01% 707
2020
Q2 		$322K Sell
1,416
-156
-10% -$30.7K ﹤0.01% 538
2020
Q1 		$239K Sell
1,572
-870
-36% -$134K ﹤0.01% 615
2019
Q4 		$367K Sell
2,442
-105
-4% -$15.3K ﹤0.01% 668
2019
Q3 		$361K Buy
+2,547
New +$351K ﹤0.01% 630
2018
Q4 		– Sell
-1,886
Closed -$233K – 952
2018
Q3 		$233K Buy
+1,886
New +$212K ﹤0.01% 917
2018
Q1 		– Sell
-2,088
Closed -$206K – 1002
2017
Q4 		$206K Buy
+2,088
New +$205K ﹤0.01% 822

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ALPS Advisors's WST Position: Q2 2026 in Review

ALPS Advisors increased its West Pharmaceutical (WST) stake by 40% in Q2 2026, buying an estimated $260K and bringing the position to 2,954 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #685.

ALPS Advisors first reported a position in WST in Q4 2017 and has held it in 23 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • ALPS Advisors held 2,954 shares of West Pharmaceutical worth $1.06M as of Q2 2026.
  • ALPS Advisors bought 849 West Pharmaceutical shares in Q2 2026, an estimated $260K.
  • West Pharmaceutical made up 0.01% of ALPS Advisors's portfolio in Q2 2026, its #685 holding.
  • ALPS Advisors first reported a position in West Pharmaceutical in Q4 2017 and has held it in 23 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.